On Invalid Date, Precision Biosciences (NASDAQ: DTIL) reported Q1 2023 earnings per share (EPS) of -$0.23, up 50% year over year. Total Precision Biosciences earnings for the quarter were -$25.06 million. In the same quarter last year, Precision Biosciences's earnings per share (EPS) was -$0.46.
As of Q2 2023, Precision Biosciences's earnings has grown year over year. Precision Biosciences's earnings in the past year totalled -$108.53 million.
What is DTIL's earnings date?
Precision Biosciences's earnings date is Invalid Date. Add DTIL to your watchlist to be reminded of DTIL's next earnings announcement.
What was DTIL's revenue last quarter?
On Invalid Date, Precision Biosciences (NASDAQ: DTIL) reported Q1 2023 revenue of $8.78 million up 164.7% year over year. In the same quarter last year, Precision Biosciences's revenue was $3.32 million.
What was DTIL's revenue growth in the past year?
As of Q2 2023, Precision Biosciences's revenue has grown -70.18% year over year. This is 139.78 percentage points lower than the US Biotechnology industry revenue growth rate of 69.59%. Precision Biosciences's revenue in the past year totalled $30.56 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.